Concepedia

Melissa L. Boby

ML

Statistics

Publications

8

Citations

721

H-Index

8

Active since

2014

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Weizmann Institute of Science

University of Johannesburg

Diamond Light Source

Melissa L. Boby is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacy, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2014–2023

8

Publications

8

SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids

Jitske Jansen, Katharina C. Reimer, James S. Nagai et al. · Cell stem cell · 2021 · 266 citations · Full text

, , +17

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, Neşe Kurt Yılmaz, Daniel Zaidmann et al. · Science · 2023 · 175 citations · Full text

, , +17

Best Practices for Constructing, Preparing, and Evaluating Protein-Ligand Binding Affinity Benchmarks [Article v1.0]

David F. Hahn, Christopher I. Bayly, Melissa L. Boby et al. · Living Journal of Computational Molecular Science · 2022 · 81 citations · Full text

, , +16

Design and evaluation of novel glutaminase inhibitors

Lee McDermott, Prema Iyer, Shawn Rimer et al. · Bioorganic & Medicinal Chemistry · 2016 · 74 citations · Full text

, , +12

Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 70 citations · Full text

, , +17

1–5 of 8